Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01980355 · ClinicalTrials.gov registry record · NA
TXA Study in Major Oncologic Surgery
A NA study, sponsored by Corewell Health West.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT01980355 is a NA study that has completed, run by Corewell Health West. The registered enrollment target is 76 participants.
The verdict
NCT01980355, a NA study, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
Major surgery can result in blood loss that can require a blood transfusion during and/or after surgery. Tranexamic acid is a medication that was first introduced in the 1960s as a treatment for heavy menstrual bleeding. Over the past 20 years it has been used and studied in patients undergoing open-heart surgery, liver transplantation, and urologic surgery. We believe tranexamic acid may possibly decrease bleeding related to major surgery, resulting in reduced blood loss, lower blood transfusion rates, and possibly decreased hospital costs related to your surgical hospital stay. In this study, you will receive either the drug tranexamic acid or a placebo. The placebo looks like the tranexamic acid, but does not have any active ingredient in it. The treatment you get will be chosen by chance, like flipping a coin. You will have equal chance of being given the tranexamic acid or the placebo. In this study, both the tranexamic acid and the placebo are considered research.
Interventions
- OTHER Placebo
- DRUG Tranexamic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2012-06-12 |
| Est. Completion | 2020-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01980355
The ClinicalTrials.gov registry entry for NCT01980355 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01980355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01980355 about?
NCT01980355 is a clinical study titled "TXA Study in Major Oncologic Surgery". Major surgery can result in blood loss that can require a blood transfusion during and/or after surgery. Tranexamic acid is a medication that was first introduced in the 1960s as a treatment for heavy menstrual bleeding. Over the past 20 years it has been used and studied in patients undergoing open...
What is the current status of trial NCT01980355?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2012-06-12. Estimated completion is 2020-07-29.
What interventions are being tested in trial NCT01980355?
The interventions under investigation include: Placebo (OTHER), Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT01980355?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.